Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Incruse Ellipta (previously Incruse)
(umeclidinium bromide)
Uses, side effects, dosage information & price range
About this medicine
Indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Common Brand Names for this Composition
The following popular commercial brand names contain umeclidinium bromide as their active ingredient composition:
Laventair Ellipta (previously Laventair)
GlaxoSmithKline Trading Services Limited
Anoro Ellipta (previously Anoro)
GlaxoSmithKline Trading Services Limited
Incruse Ellipta (previously Incruse)
GlaxoSmithKline Trading Services Limited
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
umeclidinium bromide
Category
Drugs for obstructive airway diseases
Manufacturer
GlaxoSmithKline Trading Services Limited
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.